There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b ...

Simmons University and Swedish building giant Skanska have unveiled detailed designs for the long-planned overhaul of Simmons ...

Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio" or the "Company"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.

The latest drugs for Alzheimer's disease may add years of independence to the lives of patients, but possibly only for some.

Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM" or "Psyence Biomed"), has announced that it ...

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined ...

Affimed (NASDAQ:AFMD – Get Free Report) is expected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.91) per ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Treatment Potential Clinical Pipeli ...